SRSF2 and kidney neoplasm: The analysis of immunohistochemical (IHC) data revealed that, in renal tumours, SRSF2 staining intensity was reduced by 33.3% (p = 0.0027) when compared with normal kidney tissues (Figure 1B and Figure S2).